Opposing effects of Nrf2 and Nrf2-activating compounds on the NLRP3 inflammasome independent of Nrf2-mediated gene expression
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
The transcription factor Nrf2 regulates the expression of genes required for protection from xenobiotic and oxidative stress. Under normal conditions Nrf2 is constantly degraded upon ubiquitination, mediated by the Nrf2 inhibitor Keap1. Inflammasomes represent stress‐induced protein complexes. They are critically involved in acute and chronic inflammation through caspase‐1‐mediated activation of pro‐inflammatory cytokines. Here, we demonstrate that Nrf2 is a positive regulator of the NLRP3 inflammasome. In contrast, Nrf2‐activating compounds, including the anti‐inflammatory drug dimethyl fumarate (DMF), inhibit inflammasome activation. Both effects are independent of the transcriptional activity of Nrf2 and, at least in part, not interdependent. On the other hand, NLRP3 inflammasome activation induces a rapid and partly caspase‐1‐ and Keap1‐independent degradation of Nrf2. These data argue against a simultaneous activation of both stress‐related pathways. Finally, we provide evidence that the cross‐regulation of both pathways is controlled by a physical interaction between the Nrf2/Keap1 and NLRP3 complexes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Numerous studies have suggested that Nrf2 activators such as melatonin and natural compounds inhibit NLRP3 inflammasome activation (31, 32).”
From Melatonin Attenuates LPS-Induced Acute Depressive-Like Behaviors and Microglial NLRP3 Inflammasome Activation Through the SIRT1/Nrf2 Pathway (2019) · cites this paper as [32]
In the citing paper
“Numerous studies have suggested that Nrf2 activators such as melatonin and other natural compounds inhibit NLRP3 inflammasome via suppressing ROS production (6, 32).”
From Melatonin Attenuates LPS-Induced Acute Depressive-Like Behaviors and Microglial NLRP3 Inflammasome Activation Through the SIRT1/Nrf2 Pathway (2019) · cites this paper as [32]
Citations
Cites
Schroder, K., & Tschopp, J. (2010) · Cell · doi:10.1016/j.cell.2010.01.040 · Cited by 5,475
Gout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326
Improved vectors and genome-wide libraries for CRISPR screening
Sanjana, N. E., Shalem, O., & Zhang, F. (2014) · Nature Methods · doi:10.1038/nmeth.3047 · Cited by 5,239
Cell Survival Responses to Environmental Stresses Via the Keap1-Nrf2-ARE Pathway
Kensler, T. W., Wakabayashi, N., & Biswal, S. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.46.120604.141046 · Cited by 3,630
Immunological and inflammatory functions of the interleukin-1 family
Dinarello, C. A. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132612 · Cited by 3,466
Inflammasomes in health and disease
Strowig, T., Henao-Mejia, J., Elinav, E., & Flavell, R. (2012) · Nature · doi:10.1038/nature10759 · Cited by 2,230
Conditional gene targeting in macrophages and granulocytes using LysMcre mice
Clausen, B. E., Burkhardt, C., Reith, W., Renkawitz, R., & Förster, I. (1999) · Transgenic Research · doi:10.1023/a:1008942828960 · Cited by 2,098
Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription
Kobayashi, E. H., Suzuki, T., Funayama, R., Nagashima, T., Hayashi, M., Sekine, H., Tanaka, N., Moriguchi, T., Motohashi, H., Nakayama, K., et al. (2016) · Nature Communications · doi:10.1038/ncomms11624 · Cited by 1,878
Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution
Taguchi, K., Motohashi, H., & Yamamoto, M. (2011) · Genes to Cells · doi:10.1111/j.1365-2443.2010.01473.x · Cited by 1,478
The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer
Kansanen, E., Kuosmanen, S. M., Leinonen, H., & Levonen, A.-L. (2013) · Redox Biology · doi:10.1016/j.redox.2012.10.001 · Cited by 1,313
Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase
Rossi, A., Kapahi, P., Natoli, G., Takahashi, T., Chen, Y., Karin, M., & Santoro, M. G. (2000) · Nature · doi:10.1038/47520 · Cited by 1,310
Nrf2, a Cap'n'Collar Transcription Factor, Regulates Induction of the Heme Oxygenase-1 Gene
Alam, J., Stewart, D., Touchard, C., Boinapally, S., Choi, A. M. K., & Cook, J. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.37.26071 · Cited by 1,285
Molecular basis of the Keap1–Nrf2 system
Suzuki, T., & Yamamoto, M. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.06.006 · Cited by 995
A Versatile Viral System for Expression and Depletion of Proteins in Mammalian Cells
Campeau, E., Ruhl, V. E., Rodier, F., Smith, C. L., Rahmberg, B. L., Fuss, J. O., Campisi, J., Yaswen, P., Cooper, P. K., & Kaufman, P. D. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006529 · Cited by 964
Toward clinical application of the Keap1-Nrf2 pathway
Suzuki, T., Motohashi, H., & Yamamoto, M. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.04.005 · Cited by 680
Chan, K., Lu, R., Chang, J. C., & Kan, Y. W. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13943 · Cited by 645
The Inflammasome Mediates UVB-Induced Activation and Secretion of Interleukin-1β by Keratinocytes
Feldmeyer, L., Keller, M., Niklaus, G., Hohl, D., Werner, S., & Beer, H.-D. (2007) · Current Biology · doi:10.1016/j.cub.2007.05.074 · Cited by 544
Self-citationChen, C.-J. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28075 · Cited by 476
Cytosolic DNA Triggers Inflammasome Activation in Keratinocytes in Psoriatic Lesions
Dombrowski, Y., Peric, M., Koglin, S., Kammerbauer, C., Göß, C., Anz, D., Simanski, M., Gläser, R., Harder, J., Hornung, V., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002001 · Cited by 431
Hara, H., Tsuchiya, K., Kawamura, I., Fang, R., Hernandez-Cuellar, E., Shen, Y., Mizuguchi, J., Schweighoffer, E., Tybulewicz, V., & Mitsuyama, M. (2013) · Nature Immunology · doi:10.1038/ni.2749 · Cited by 381
ASC Speck Formation as a Readout for Inflammasome Activation
Stutz, A., Horvath, G. L., Monks, B. G., & Latz, E. (2013) · Methods in Molecular Biology · doi:10.1007/978-1-62703-523-1_8 · Cited by 332
Lin, W., Wu, R. T., Wu, T., Khor, T.-O., Wang, H., & Kong, A.-N. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.07.036 · Cited by 323
Fumarate Is Cardioprotective via Activation of the Nrf2 Antioxidant Pathway
Ashrafian, H., Czibik, G., Bellahcene, M., Aksentijević, D., Smith, A. C., Mitchell, S. J., Dodd, M. S., Kirwan, J., Byrne, J. J., Ludwig, C., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.01.017 · Cited by 302
Freigang, S., Ampenberger, F., Spohn, G., Heer, S., Shamshiev, A. T., Kisielow, J., Hersberger, M., Yamamoto, M., Bachmann, M. F., & Kopf, M. (2011) · European Journal of Immunology · doi:10.1002/eji.201041316 · Cited by 300
Dimethyl fumarate treatment induces adaptive and innate immune modulation independent of Nrf2
Schulze-Topphoff, U., Varrin-Doyer, M., Pekarek, K., Spencer, C. M., Shetty, A., Sagan, S. A., Cree, B. A. C., Sobel, R. A., Wipke, B. T., Steinman, L., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1603907113 · Cited by 293
Enhancing Nrf2 Pathway by Disruption of Keap1 in Myeloid Leukocytes Protects against Sepsis
Kong, X., Thimmulappa, R., Craciun, F., Harvey, C., Singh, A., Kombairaju, P., Reddy, S. P., Remick, D., & Biswal, S. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201102-0271oc · Cited by 222
Inoue, M., Williams, K. L., Oliver, T., Vandenabeele, P., Rajan, J. V., Miao, E. A., & Shinohara, M. L. (2012) · Science Signaling · doi:10.1126/scisignal.2002767 · Cited by 194
Nrf2 links epidermal barrier function with antioxidant defense
Schäfer, M., Farwanah, H., Willrodt, A., Huebner, A. J., Sandhoff, K., Roop, D., Hohl, D., Bloch, W., & Werner, S. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201200219 · Cited by 186
Self-citationNuclear Factor E2-related Factor-2 (Nrf2) Is Required for NLRP3 and AIM2 Inflammasome Activation
Zhao, C., Gillette, D. D., Li, X., Zhang, Z., & Wen, H. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.563114 · Cited by 185
Nrf2 establishes a glutathione-mediated gradient of UVB cytoprotection in the epidermis
Schäfer, M., Dütsch, S., auf dem Keller, U., Navid, F., Schwarz, A., Johnson, D. A., Johnson, J. A., & Werner, S. (2010) · Genes & Development · doi:10.1101/gad.568810 · Cited by 175
Self-citationSulforaphane inhibits multiple inflammasomes through an Nrf2-independent mechanism
Greaney, A. J., Maier, N. K., Leppla, S. H., & Moayeri, M. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.3a0415-155rr · Cited by 165
Caspase-4 Is Required for Activation of Inflammasomes
Sollberger, G., Strittmatter, G. E., Kistowska, M., French, L. E., & Beer, H.-D. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1101620 · Cited by 162
Self-citationLiu, X., Zhou, W., Zhang, X., Lü, P., Du, Q., Tao, L., Ding, Y., Wang, Y., & Hu, R. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.05.002 · Cited by 151
Li, B., Cui, W., Liu, J., Li, R., Liu, Q., Xie, X.-H., Ge, X., Zhang, J., Song, X., Wang, Y., et al. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.10.002 · Cited by 143
McGuire, V. A., Ruiz-Zorrilla Diez, T., Emmerich, C. H., Strickson, S., Ritorto, M. S., Sutavani, R. V., Weiβ, A., Houslay, K. F., Knebel, A., Meakin, P. J., et al. (2016) · Scientific Reports · doi:10.1038/srep31159 · Cited by 110
Diagnosis and therapy of cutaneous and mucocutaneous Leishmaniasis in Germany
Boecken, G., Sunderkötter, C. H., Bogdan, C., Weitzel, T., Fischer, M., Müller, A., Löbermann, M., Anders, G., von Stebut, E., Schunk, M., et al. (2011) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/j.1610-0379.2011.07820.x · Cited by 100
Roles Nrf2 Plays in Myeloid Cells and Related Disorders
Kobayashi, E., Suzuki, T., & Yamamoto, M. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/529219 · Cited by 94
Caspase-1 Activity Is Required for UVB-Induced Apoptosis of Human Keratinocytes
Sollberger, G., Strittmatter, G. E., Grossi, S., Garstkiewicz, M., Keller, U. A. D., French, L. E., & Beer, H. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.551 · Cited by 91
Self-citationThe Cyclopentenone Prostaglandin 15d-PGJ2 Inhibits the NLRP1 and NLRP3 Inflammasomes
Maier, N. K., Leppla, S. H., & Moayeri, M. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401611 · Cited by 63
Fox, R., & Phillips, J. (2013) · Seminars in Neurology · doi:10.1055/s-0033-1343796 · Cited by 62
Gasperini, C., Ruggieri, S., & Tortorella, C. (2014) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s53285 · Cited by 49
Miglio, G., Veglia, E., & Fantozzi, R. (2015) · International Immunopharmacology · doi:10.1016/j.intimp.2015.06.011 · Cited by 42
Dimethyl fumarate: a Janus-faced substance?
Kees, F. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.804912 · Cited by 29
Neue Erkenntnisse zu Fumarsäureestern (Fumaderm®): Ergebnisse eines Experten‐Workshops
Mrowietz, U., Adamczyk, A., Augustin, M., Boehncke, W., Bonnekoh, B., Gambichler, T., Hengge, U., Lippert, U., Ludwig, R. J., Luger, T. A., et al. (2011) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/j.1610-0379.2011.07765.x · Cited by 10
Cited by
The Immunomodulatory Metabolite Itaconate Modifies NLRP3 and Inhibits Inflammasome Activation
Hooftman, A., Angiari, S., Hester, S., Corcoran, S. E., Runtsch, M. C., Ling, C., Ruzek, M. C., Slivka, P. F., McGettrick, A. F., Banahan, K., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.07.016 · Cited by 609
“, 2018), leading to activation of NRF2, a protein that is thought to regulate NLRP3 inflammasome activation (Garstkiewicz et al., 2017; Zhao et al., 2014).”
BackgroundArioz, B. I., Tastan, B., Tarakcioglu, E., Tufekci, K. U., Olcum, M., Ersoy, N., Bagriyanik, A., Genc, K., & Genc, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01511 · Cited by 516
“Numerous studies have suggested that Nrf2 activators such as melatonin and natural compounds inhibit NLRP3 inflammasome activation (31, 32).”
BackgroundBruton’s Tyrosine Kinase: An Emerging Key Player in Innate Immunity
Weber, A. N. R., Bittner, Z., Liu, X., Dang, T.-M., Radsak, M. P., & Brunner, C. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01454 · Cited by 269
“Whether BTK also plays a role in the alternative NLRP3 inflammasome dependent on caspase-11 remains to be investigated.”
BackgroundInfluentialThe Crosstalk between Nrf2 and Inflammasomes
Hennig, P., Garstkiewicz, M., Grossi, S., Di Filippo, M., French, L., & Beer, H.-D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020562 · Cited by 253
“It is likely that this loop is more relevant before than after inflammasome assembly, since Nrf2 is quickly degraded upon inflammasome activation [63].”
BackgroundInfluentialSelf-citationLoop Between NLRP3 Inflammasome and Reactive Oxygen Species
Dominic, A., Le, N.-T., & Takahashi, M. (2022) · Antioxidants & Redox Signaling · doi:10.1089/ars.2020.8257 · Cited by 242
“(25) recently reported interesting results that Nrf2 is a positive regulator of the NLRP3 in-flammasome, whereas Nrf2-activating compounds inhibit NLRP3 inflammasome activation.”
Metadata
- Authors
- Garstkiewicz, M., Strittmatter, G. E., Grossi, S., Sand, J., Fenini, G., Werner, S., French, L. E., & Beer, H.
- Affiliations
- University Hospital Zurich (CH)
- Institute of Molecular Health Sciences (CH)
- Corresponding author
- Beer, Hans‐Dietmar
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 2017-04-10
- Volume
- 47
- Issue
- 5
- Pages
- 806-817
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W2592459614
- Cited by
- 72
- References
- 44
- Citations by year
- 2026: 7 · 2025: 13 · 2024: 6 · 2023: 5 · 2022: 6 · 2021: 7 · 2020: 10 · 2019: 5 · 2018: 9 · 2017: 4
- FWCI
- 3.13
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Locations
- European Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
- Zurich Open Repository and Archive (University of Zurich)
- Funders
- Gottfried und Julia Bangerter-Rhyner-Stiftung
- Wilhelm Sander-Stiftung (2015.035.1)
- Promedica Stiftung
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (31003A_132450)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Keywords
- Nrf2, NLRP3 inflammasome, Keap1, dimethyl fumarate, caspase-1, inflammasome activation, Nrf2 degradation, oxidative stress, inflammation, protein-protein interaction, anti-inflammatory agents
- MeSH terms
- Dimethyl Fumarate, NLR Family, Pyrin Domain-Containing 3 Protein, Animals, Gene Expression Regulation, Humans, Inflammation, Signal Transduction, Keratinocytes, Cytokines, Caspase 1, NF-E2-Related Factor 2, Mice, Inflammasomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.